Navigation Links
AdvanDx Closes $8 Million Financing Round and Elects New Board Member
Date:8/18/2009

WOBURN, Mass. and VEDBAEK, Denmark, Aug. 18 /PRNewswire/ -- AdvanDx today announced it has closed another $8 million in financing from existing stockholders, SLS Venture and LD Pensions. The additional investment is part of a series C round of financing, the first part of which was closed in September 2007, and will be used to fund the expansion of AdvanDx's molecular diagnostics product offering as well as its international sales and marketing activities.

In addition to the financing, stockholders elected Tina W. Christensen to AdvanDx board of directors. Ms. Christensen is a Vice President and CFO at the Danish health insurance company "danmark" which specializes in providing 2 million Danish citizens with supplemental health insurance to the Danish National Health Service.

"We continue to see increased adoption of our clinical diagnostic products and this latest financing will enable us to add new tests to our product portfolio and to continue to expand our customer base. We greatly appreciate our investors' strong commitment to AdvanDx and our future," said Thais T. Johansen, President and CEO of AdvanDx. "We also very much look forward to Tina W. Christensen's participation on our board of directors and the experience she brings from the health care and health insurance industry," Johansen continued.

About AdvanDx

AdvanDx is a leading provider of advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. AdvanDx's easy-to-use products provide fast and accurate results that enable dramatic improvements in patient care and help to save lives and reduce hospital costs.

AdvanDx's products employ standard laboratory techniques and equipment to reduce startup, implementation, technician and maintenance time, while providing fast results without sacrificing accuracy. Major medical centers, reference labs, government institutions and community hospitals throughout the United States, Europe and Asia rely on AdvanDx products as integral parts of their medical care.

For more information visit www.AdvanDx.com

About Scandinavian Life Science Venture

SLS Venture, an international venture capital company with a Scandinavian base is one of the largest in Scandinavia focusing on the life sciences sector with approximately euro 270 million under management. SLS Venture has invested in 36 pharmaceutical, medtech and biotech companies to date. Portfolio companies include Aerocrine, Exiqon, Symphogen, Light Sciences Oncology and NeuroNova.

For more information, please visit www.slsventure.com

About LD Pensions

LD Pensions is one of Denmark's largest pension funds with more than US$10 billion under management. LD Pensions has a long-term and highly selective investment strategy. Investments made in unlisted companies are based on a fundamental analysis of the opportunity with an objective to hold the investment for a minimum of 3-5 years in order to position the company for a strategic sale or stock exchange listing. It is important for LD Pensions to demonstrate a high discipline of active ownership with respect to corporate governance, information policy and the ability to meet the requirements and expectations from the surrounding society in terms of responsible environmental management and social responsibility.

For more information please visit www.ld.dk

PN1674A


'/>"/>
SOURCE AdvanDx
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AdvanDx Receives FDA 510(k) Clearance for GBS PNA FISH(R) for Rapid Detection of Group B Strep from Lim Broths
2. AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R)
3. HeartWare International, Inc. Closes US$60 Million Financing
4. Emdeon Closes The Sentinel Group Acquisition, Implements First Customer in Less than 30 Days
5. Croff Enterprises, Inc. Closes Merger and Will Change Name to Americas Minority Health Network, Inc.
6. Paradigm Spine Closes $21.5 Million Financing and Announces Promotion of Matt Stuttle to Position of Vice President, US Sales
7. Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery
8. Providence Service Corporation to Report Second Quarter 2009 Results on Monday, August 10th After the Market Closes
9. SecureWorks Closes Acquisition of VeriSigns Managed Security Services Business
10. BioMed Realty Trust Closes New $18 Million Secured Loan
11. I-Therapeutix, Inc. Closes $15 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , ... May 02, 2016 , ... The 2016 World Ultimate & Guts Championship (WUGC) ... at Manhattan College, made the cut. The WUGC is being held in London, England this ... the gold in the men’s division, another gold in the women’s masters division, and a ...
(Date:5/2/2016)... ... , ... Pregnancy Awareness Month offers a great time to get familiar with ... are ready to have a baby, it’s best to get started before age becomes ... Personal Conception & Pregnancy Organizer, written for women who plan on becoming pregnant to ...
(Date:5/2/2016)... ... May 02, 2016 , ... A ... completed two groundbreaking studies that determined that the adjustability and adaptability of pediatric ... the prevention of pressure injuries, which are now referred to as “pressure injuries” ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. (AIS) ... B Payment Model Could Transform the Pharma Landscape .” CMS recently proposed a test ... spend on provider-administered drugs while preserving care provided to beneficiaries. The webinar will review ...
(Date:5/2/2016)... ... May 02, 2016 , ... The Evolve Paddle Board Company- ... prices announced today the outcome of their partnership with Yoloha Yoga- producers of high ... Yoga Board.” , SUP yoga has seen a dramatic rise in popularity throughout the ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... PUNE, India , April 29, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" market research report ... pipeline, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ... press releases. It also reviews key players involved ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... will notably complement the company,s valve repair and ... the move also places Abbott more firmly into ... one of the fastest growing device areas, with ... to its recent report,  Advanced Remote Patient ...
Breaking Medicine Technology: